SCHEMBL13367605

SCHEMBL13367605

CN(c1ccc(-c2ccccc2)cc1)c1ccc2c3c(cccc13)-c1ccccc1-2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
USP2 O75604 2/20 0.43
POLB P06746 1/20 0.41
CHKA P35790 7/20 0.40
CRHBP P24387 2/20 0.40
CRHR2 Q13324 2/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
MAPT P10636 3/20 0.37
PABPC1 P11940 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
KDM1A O60341 1/20 0.36
CHKB Q9Y259 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CASP1 P29466 2/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13367397 0.90 MEN1 (0.48) MEN1KMT2AUSP2POLBCHKA
SCHEMBL23546630 0.84 CRHBP (0.42) MEN1KMT2AUSP2POLBCRHBP
SCHEMBL14491574 0.84 CRHBP (0.42) MEN1KMT2AUSP2POLBCRHBP
SCHEMBL13367404 0.83 MEN1 (0.50) MEN1KMT2AUSP2POLBCRHBP
SCHEMBL23546674 0.83 CRHBP (0.41) MEN1KMT2AUSP2POLBCRHBP
SCHEMBL12566482 0.83 CRHBP (0.41) MEN1KMT2AUSP2POLBCRHBP
SCHEMBL18904410 0.81 CRHBP (0.40) MEN1KMT2AUSP2POLBCRHBP
SCHEMBL5002787 0.81 CRHBP (0.42) MEN1KMT2AUSP2POLBCRHBP
SCHEMBL13338690 0.81 MAPT (0.41) MEN1KMT2AUSP2POLBCRHBP
SCHEMBL14010647 0.80 CRHBP (0.44) MEN1KMT2AUSP2POLBCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 MEN1 3828/4885KMT2A 3622/4885USP2 4266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.